BCAB
Bioatla·NASDAQ
--
--(--)
--
--(--)
2.44 / 10
Underperform
Technical analysis rates BCAB as underperform with a 2.44/10 score. Both long lower and upper shadows appear, signaling bearish pressure and no bullish cues. Recent five‑day trend is weak, suggesting further decline risk.
Analysis Checks(0/2)
Long Lower Shadow
Score3.56/10
Win Rate48.57%
Hist. Signals105
Avg Return1.55%
Score3.56/10
Win Rate48.57%
Hist. Signals105
Avg Return1.55%
Long Upper Shadow
Score1.31/10
Win Rate39.64%
Hist. Signals111
Avg Return-0.26%
Score1.31/10
Win Rate39.64%
Hist. Signals111
Avg Return-0.26%
Long Lower Shadow
Score3.56/10
Win Rate48.57%
Hist. Signals105
Avg Return1.55%
Score3.56/10
Win Rate48.57%
Hist. Signals105
Avg Return1.55%
Long Upper Shadow
Score1.31/10
Win Rate39.64%
Hist. Signals111
Avg Return-0.26%
Score1.31/10
Win Rate39.64%
Hist. Signals111
Avg Return-0.26%
Technical Analysis of BCAB?
- BCAB presents a Underperform setup with a Technical Score of 2.44/10. Key technical indicators highlight an RSI of 39.06 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 0.21. Traders should monitor key support at 0.14 and resistance at 0.16.
